Analyst Ratings for Aeglea Biotherapeutics (AGLE)

AGLE Rating Summary

  |   Expand Research on AGLE
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8.8 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/4/2020 Piper Sandler Edward Tenthoff New Coverage Overweight
(N/A)
N/A
(N/A)
7.77
(7.05)
-9.27% Details
5/21/2019 H.C. Wainwright
» Updated 2/25/2020
Edward White New Coverage Buy
(N/A)
24.00
(20.00)
6.48
(7.05)
8.8% Details
Like AGLE Ratings? Also take a look at PRAX, IKNA, EEFT, DOOR

AGLE Ratings News